When was Future Fields founded?

Future Fields was founded in 2017 and raised its 1st funding round 3 years after it was founded.

Where is Future Fields located?

Future Fields is headquartered in Edmonton, Canada.

How many employees does Future Fields have?

As of May 31, 2026, the latest employee count at Future Fields is 44.

Is Future Fields a funded company?

Future Fields is a funded company, having raised a total of $21.5M across 4 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Aug 25, 2020.

When was the latest funding round of Future Fields?

Future Fields' latest funding was a $***** Series A round on Jun 17, 2025, with participation from 7 investors.

Where does Future Fields rank among its competitors?

Future Fields ranks 3rd amongst 65 active competitors, of which 20 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was Laigo Biotechnology, which secured $6.36M in Mar, 2026.

Who are the top competitors of Future Fields?

Future Fields' top competitors include Qkine, Orf Genetics and MarraBio. Among them, Laigo Biotechnology secured the most recent funding round in March, 2026.

Future Fields - 2026 Company Profile, Funding & Competitors

Future Fields is a series A company based in Edmonton (Canada), founded in 2017. It operates as a Biomanufacturing unit for serum-free, bioactive growth factors, and other recombinant proteins. Future Fields has raised $21.5M in funding from investors like Bee Partners, Y Combinator and BDC. The company has 65 active competitors, including 20 funded and 3 that have exited. Its top competitors include companies like Qkine, Orf Genetics and MarraBio.

Company Details

Biomanufacturing unit for serum-free, bioactive growth factors, and other recombinant proteins. The company has developed a platform called EntoEngine that assists in the production of serum-free medical products. They also offer various products and services related to recombinant proteins.

Key Metrics

Founded Year

2017

Location

Edmonton, Canada

Stage

Series A

Total Funding

$21.5M in 4 rounds

Latest Funding Round

Series A, Jun 17, 2025, $*****

Investors

Bee Partners & 22 more

Ranked

3^rd among 65 active competitors

Employee Count

44 as on May 31, 2026

Similar Companies

Qkine & 65 more

View Future Fields' full profile

Future Fields has raised a total funding of $21.5M over 4 rounds. Its first funding round was on Aug 25, 2020. Its latest funding round was a Series A round on Jun 17, 2025 for $*****. 7 investors participated in its latest round. Future Fields has 21 institutional investors and 2 angel investors.

Here is the list of recent funding rounds of Future Fields:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 17, 2025	2132198	Series A	5775489	9388157	5612408	7188660
Feb 22, 2023	4365166	Seed	7775916	8496978	1583183	Builders VC & 7 more
Feb 25, 2021	3152267	Seed	3373368	9548887	Bee Partners	Pioneer Fund & 2 more

Access funding benchmarks and valuations. Sign up today!

View details of Future Fields's funding rounds and investors

Future Fields' employee count trend

Future Fields has 44 employees as of May 26. Here is Future Fields's employee count trend over the years:

Uncover Future Fields' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Future Fields include Qkine, Orf Genetics and MarraBio. Here is the list of Top 10 competitors of Future Fields, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Qkine 2016, Cambridge (United Kingdom), Series A	Developer of animal-free growth factors for life science applications	$8.15M	Parkwalk, Cambridge Enterprise & 17 others	60/100
2nd	Orf Genetics 2001, Kopavogur (Iceland), Series A	Developer of recombinant protein technology	$5.87M	EIC Fund, Europa	56/100
3rd	Future Fields 2017, Edmonton (Canada), Series A	Biomanufacturing unit for serum-free, bioactive growth factors, and other recombinant proteins	$21.5M	Y Combinator, BDC & 21 others	55/100
4th	MarraBio 2011, Newcastle Upon Tyne (United Kingdom), Seed	Biotechnology research company that provides bacterial protein polymers	-	Maven Capital Partners, TCS Biosciences & 2 others	48/100
5th	Laigo Biotechnology 2023, Utrecht (Netherlands), Seed	Developer of targeted protein degradation technology for therapeutic applications	$19.8M	Kurma Partners, Curie Capital & 8 others	47/100
6th	Core Biogenesis 2020, Paris (France), Series A	Provider of UBaaS platform for recombinant protein bioproduction	$14.1M	XAnge, Plug and Play Tech Center & 6 others	46/100
7th	Hunan Zhongsheng Quanpeptide Biotechnology 2017, Zhuzhou (China), Series B	Developer of peptide discovery technology, peptide libraries, and related research products	$47.9M	CDH, Xjsci & 7 others	43/100
8th	Protera 2015, Sunnyvale (United States), Series A	Platform developing protein-based on enzyme technology	$15.8M	Sofinnova Partners, IndieBio & 4 others	41/100
9th	Gearbox Biosciences 2021, Tartu (Estonia), Seed	Developer of microbial platform for antibiotic-free and growth-decoupled protein production	$402K	Specialist, UniTartu Ventures & 1 others	39/100
10th	KAICO 2018, Fukuoka (Japan), Series B	Manufacturer of portfolio of proteins and other biological cytokines and enzymes	$8.15M	Tokyo Century, Mizuho Capital & 8 others	38/100